Impact of Baseline Vision on Outcomes in Diabetic Macular Edema in VISTA/VIVID.
Saved in:
| Title: | Impact of Baseline Vision on Outcomes in Diabetic Macular Edema in VISTA/VIVID. |
|---|---|
| Authors: | Singer MA; Medical Center of Ophthalmology, University of Texas Health Science Center, San Antonio, Texas., Grewal DS; Duke University School of Medicine, Durham, North Carolina., O'Brien P; University of the Incarnate Word School of Osteopathic Medicine, San Antonio, Texas., Silva F; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Du W; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., B G; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Moini H; Regeneron Pharmaceuticals, Inc., Tarrytown, New York., Barakat MR; Retina Macula Institute of Arizona, Scottsdale, Arizona; University of Arizona College of Medicine - Phoenix, Phoenix, Arizona. Electronic address: mark.barakat@azretinamacula.com. |
| Corporate Authors: | VISTA and VIVID study investigators |
| Source: | Ophthalmology. Retina [Ophthalmol Retina] 2025 Jun; Vol. 9 (6), pp. 598-601. Date of Electronic Publication: 2025 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 2468-6530 |
|---|---|
| DOI: | 10.1016/j.oret.2025.01.016 |
